Back to search

Article

The clinical value of genetic testing in lung squamous cell carcinoma: A retrospective study

2026-04-05

Abstract excerpt

<title>Abstract</title> <p>Objectives To assess the necessity and clinical value of genetic testing in lung squamous cell carcinoma (LSCC) diagnosis and treatment. Methods This retrospective study enrolled 1,515 LSCC patients from Chongqing University Cancer Hospital. Medical records were reviewed to analyze gene mutations, treatment and healthcare economic outcomes for clinical benefit evaluation. Results Of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1224b41-f8e1-563b-8a1d-e9c2270d9ecd
DOI
10.21203/rs.3.rs-9260557/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The clinical value of genetic testing in lung squamous cell carcinoma: A retrospective studyDOI 10.21203/rs.3.rs-9260557/v1
Biomarkers and molecular profiling in non-small cell lung cancer: an expanding role and its managed care implications.Semantic proximity
The co-mutation of EGFR and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patientsSemantic proximity
Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.Semantic proximity
Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer.Semantic proximity
Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer.Semantic proximity
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.Semantic proximity
Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.Semantic proximity
Somatic gene mutations and their association with treatment outcomes among Indo-Asian Lung Cancer patients.Semantic proximity
Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma.Semantic proximity
The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China.Semantic proximity
Association of Next Generation Sequencing and Routine Testing With Clinical Outcomes of Advanced Non-small Cell Lung Cancer Patients in a Real-world SettingSemantic proximity
Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations.Semantic proximity
Select a neighboring publication to make it the new centre.